1.64  0.03 (1.86%)		12-05 16:00
Open: 1.6 High: 1.68 Volume: 225,864		Pre. Close: 1.61 Low: 1.5601 Market Cap: 86(M)

Short term
Mid term
Targets	6-month :	1.96	1-year :	2.29
Resists	First :	1.67	Second :	1.96
Pivot price	1.35
Supports	First :	1.31	Second :	1.09
MAs	MA(5) :	1.5	MA(20) :	1.34
	MA(100) :	1.42	MA(250) :	0
MACD	MACD :	0	Signal :	-0.1
%K %D	K(14,3) :	93	D(3) :	85.5
RSI	RSI(14): 63.8
52-week	High :	3.4	Low :	1.09

Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.
[ CBUS ] has closed It is unclear right now based on current values. 72.6% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 1 days. This is a sign that the current trend might continue.

If tomorrow:	Open lower	Open higher
High:	1.68 - 1.69	1.69 - 1.69
Low:	1.54 - 1.55	1.55 - 1.56
Close:	1.63 - 1.64	1.64 - 1.65

Cibus, Inc., a agricultural technology company, develops and licenses plant traits to seed companies for royalties. The company primarily focus on trait productivity in two areas, including productivity traits that enable farmers to have higher yields and reduce the use of the crop protection chemicals and fertilizers; and sustainable ingredients that enable corporations to replace ingredients that are fossil fuel based or whose production results in increased greenhouse gases. The company is based in San Diego, California.

Tue, 18 Nov 2025
Canaccord Genuity Remains a Buy on Cibus (CBUS) - The Globe and Mail

Sat, 15 Nov 2025
Cibus, Inc. Earnings Call Highlights Progress and Challenges - TipRanks

Fri, 14 Nov 2025
Cibus Reports Q3 2025 Results and Advances Rice Trait Commercialization Strategy - iGrow News

Thu, 13 Nov 2025
Cibus Inc (CBUS) Q3 2025 Earnings Call Highlights: Strategic Advances Amid Revenue Challenges - Yahoo Finance

Thu, 13 Nov 2025
Cibus Reports Third Quarter Financial Results and Provides Year-to-Date Business Update for 2025 - GlobeNewswire

Thu, 13 Nov 2025
Earnings call transcript: Cibus Q3 2025 reveals earnings miss, stock dips - Investing.com

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Outperform
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Underperform
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Underperform
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Underperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Underperform
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Underperform

Exchange: NASDAQ
Sector: Healthcare
Industry: Biotechnology
Shares Out	0 (M)
Shares Float	53 (M)
Held by Insiders	3.658e+007 (%)
Held by Institutions	33.4 (%)
Shares Short	1,400 (K)
Shares Short P.Month	0 (K)

EPS	-6.575e+007
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	0
Profit Margin	0 %
Operating Margin	-2 %
Return on Assets (ttm)	510.2 %
Return on Equity (ttm)	-12.9 %
Qtrly Rev. Growth	3.79e+006 %
Gross Profit (p.s.)	-38.96
Sales Per Share	-90.01
EBITDA (p.s.)	2.33951e+006
Qtrly Earnings Growth	-2.8 %
Operating Cash Flow	0 (M)
Levered Free Cash Flow	-51 (M)

PE Ratio	-0.01
PEG Ratio	0
Price to Book value	0
Price to Sales	-0.02
Price to Cash Flow	2.76

Dividend	0
Forward Dividend	924740
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.